Related Experiment Video
Updated: Dec 11, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
Insulin Bolus Calculator: Lessons Learned from Institutional Experience
Valerie D Nolt1, Adrian Araya2, Mohammed B Ateya1
1Department of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
Journal of Diabetes Science and Technology
|August 25, 2020
Summary
Electronic insulin calculators improve inpatient glycemic control and safety. This study details the multidisciplinary integration of an insulin calculator into an electronic health record, highlighting implementation barriers and benefits for patient care.
Area of Science:
- Clinical Informatics
- Endocrinology
- Hospital Medicine
Background:
- Insulin bolus calculators enhance glycemic control and patient safety.
- Inpatient insulin calculator implementation is increasing.
- Multidisciplinary teams are crucial for calculator design and review.
Purpose of the Study:
- To describe the integration of an insulin calculator into an electronic health record (EHR).
- To identify barriers and pitfalls encountered during clinical integration.
- To highlight benefits and lessons learned from EHR-integrated insulin calculator use.
Main Methods:
- Multidisciplinary team effort for EHR integration.
- Review of implementation process to identify obstacles.
- Analysis of calculator utilization for potential benefits and unintended consequences.
Main Results:
- Identified several obstacles to effective care during implementation.
- Discussed barriers to utilization and clinical integration pitfalls.
- Described benefits including patient education, insulin timing, ketone correction, care variation, and maximum bolus.
Conclusions:
- Sharing lessons learned from electronic insulin calculator order sets improves hospital patient care.
- Successful integration requires addressing identified barriers.
- Multidisciplinary collaboration is key to optimizing insulin calculator use in hospitals.
More Related Videos
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
539
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
539
01:27Insulin Formulations: Types and Delivery
532
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
532
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
562
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
562
01:18Two-Compartment Open Model: IV Bolus Administration
940
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
940
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.0K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.0K
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
242
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
242